Prognostic Value of Urinary Calprotectin, NGAL and KIM-1 in Chronic Kidney Disease
Conclusion: In contrast to the traditional biomarker “albuminuria”, neither the inflammatory biomarker calprotectin, nor the tubular biomarkers NGAL and KIM-1, provide robust prognostic information on the loss or renal function in a heterogeneous CKD population. All of them, however, are candidate prognostic biomarkers in primarily inflammatory re nal diseases.Kidney Blood Press Res 2018;43:1255 –1262
A study of modern hunter-gatherer groups found that they exhibit generally excellent metabolic health while consuming a wide range of diets.
DIABETES type 2 risk could be lowered by making some diet or lifestyle changes. You could prevent high blood sugar symptoms and signs by drinking tea, it ’s been claimed. But how much tea should you drink every day to avoid diabetes?
President Uhuru Kenyatta signs the Universal Health Coverage charter during the launch of the UHC pilot programme in Kisumu on 13 December 2018. Photo courtesy: PSCUBy Sicily Kariuki and Siddharth ChatterjeeNAIROBI, Kenya, Dec 18 2018 (IPS)According to Director-General of the World Health Organization (WHO) Dr Tedros Ghebreyesus, the implementation of UHC is “more a political than an economic challenge”. Of all the Sustainable Development Goals, few would rival good health as the definition of a country that has a sustainable, inclusive, peaceful and prosperous future, and the launch this week of the pilot phas...
A new review of existing research examines the effect of the gut bacteria composition on the effectiveness of type 2 diabetes medications.
Sura Al Zoubi, Jianmin Chen, Catherine Murphy, Lukas Martin, Fausto Chiazza, Debora Collotta, Muhammad M. Yaqoob, Massimo Collino, Christoph Thiemermann
To what extent are sex hormone levels involved in the development and progression of chronic kidney disease?Current Opinion in Nephrology and Hypertension
This article reviews the available recent inform ation on HCV infection and CKD, including the association between these conditions and their effect on each other, and prevention, evaluation, and management of HCV infection in persons with CKD. This review looks at this issue particularly from the perspective of readers in Asia, especially India, since the epidemiology of HCV-CKD association and the repertoire of anti-HCV drugs available in this region differ from those elsewhere.
ConclusionsISLs administration during pregnancy appears to be safe and may represent a novel strategy for GDM prevention. In particular, the double administration of MYO 2 g per day may improve the glycemic homeostasis and may reduce GDM rate and preterm delivery rate.
Abstract Chronic kidney disease (CKD) includes all clinical features and complications during the progression of various kidney conditions towards end-stage renal disease (ESRD). These conditions include immune and inflammatory disease such as: primary and hepatitis C virus (HCV)-related glomerulonephritis; infectious disease such as pyelonephritis with or without reflux and tuberculosis; vascular disease such as chronic ischemic nephropathy; hereditary and congenital disease such as polycystic disease and congenital cystic dysplasia; metabolic disease including diabetes and hyperuricemia; and systemic disease (co...